Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (51-60 of 278) with videos related to

Pageof 28
Sort By:
Current HIV/AIDS Reports|June 14, 2014
Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challengeNeelja Kumar, Mark A Perazella
Kidney International|February 12, 2015
New drug toxicities in the onco-nephrology worldMark A Perazella, Hassan Izzedine
Kidney International|July 1, 2015
The Authors ReplyMark A Perazella, Hassan Izzedine
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 2, 2020
NSAIDs in CKD: Are They Safe?Megan Baker, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Thrombotic microangiopathy, cancer, and cancer drugsHassan Izzedine, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2018
Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019Corey Cavanaugh, Mark A Perazella
The American Journal of Medicine|April 1, 2009
Renal effects of anti-angiogenesis therapy: update for the internistFaina Gurevich, Mark A Perazella
Current Drug Safety|August 12, 2008
Nephrotoxicity associated with antiretroviral therapy in HIV-infected patientsMira Rho, Mark A Perazella
Seminars in Dialysis|March 5, 2002
Cardiac troponins: utility in renal insufficiency and end-stage renal diseaseSuzanne Watnick, Mark A Perazella
Kidney360|August 31, 2023
A Patient with an Unusual Cause of AKI and Scrotal SwellingDaniel Gomez, Mark A Perazella
Pageof 28

Showing results (51-60 of 278) with videos related to

Sort By:
Pageof 28
Current HIV/AIDS Reports|June 14, 2014
Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challengeNeelja Kumar, Mark A Perazella
Kidney International|February 12, 2015
New drug toxicities in the onco-nephrology worldMark A Perazella, Hassan Izzedine
Kidney International|July 1, 2015
The Authors ReplyMark A Perazella, Hassan Izzedine
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 2, 2020
NSAIDs in CKD: Are They Safe?Megan Baker, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Thrombotic microangiopathy, cancer, and cancer drugsHassan Izzedine, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2018
Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019Corey Cavanaugh, Mark A Perazella
The American Journal of Medicine|April 1, 2009
Renal effects of anti-angiogenesis therapy: update for the internistFaina Gurevich, Mark A Perazella
Current Drug Safety|August 12, 2008
Nephrotoxicity associated with antiretroviral therapy in HIV-infected patientsMira Rho, Mark A Perazella
Seminars in Dialysis|March 5, 2002
Cardiac troponins: utility in renal insufficiency and end-stage renal diseaseSuzanne Watnick, Mark A Perazella
Kidney360|August 31, 2023
A Patient with an Unusual Cause of AKI and Scrotal SwellingDaniel Gomez, Mark A Perazella
Pageof 28